[1]李小东,郭永涛,赵洪刚,等.CT引导125I粒子植入治疗晚期非小细胞肺癌的应用[J].国际放射医学核医学杂志,2007,31(6):377-380.
 LI Xiao-dong,GUO Yong-tao,ZHAO Hong-gang,et al.The image guided 125I seeds implantation treatment terminal non small cell lung carcinoma research of application[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(6):377-380.
点击复制

CT引导125I粒子植入治疗晚期非小细胞肺癌的应用(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
31
期数:
2007年第6期
页码:
377-380
栏目:
临床放射医学
出版日期:
1900-01-01

文章信息/Info

Title:
The image guided 125I seeds implantation treatment terminal non small cell lung carcinoma research of application
作者:
李小东1 郭永涛2 赵洪刚2 张遵城2 董华2 冯仲苏1 柴树德3 郑广钧3
1. 300211 天津, 天津医科大学第二医院放疗科;
2. 300211 天津, 天津医科大学第二医院核医学科;
3. 300211 天津, 天津医科大学第二医院胸心外科
Author(s):
LI Xiao-dong1 GUO Yong-tao2 ZHAO Hong-gang2 ZHANG Zun-cheng2 DONG Hua2 FENG Zhong-shu1 CAI Shu-deng3 ZHENG Guang-jun3
1. Department of Nuclear Medicine, Second Hospital, Tianjin Medical University, Tianjin 300211, China;
2. Department of Radiotherapy, Second Hospital, Tianjin Medical University, Tianjin 300211, China;
3. Department of Cardiothoracic Surgery, Second Hospital, Tianjin Medical University, Tianjin 300211, China
关键词:
碘放射性同位素体层摄影术X线计算机近距离放射疗法非小细胞肺药物疗法对比研究
Keywords:
Iodine radioctive isotopeTomographyX-rays computerBrachytherapycarcinomanon small cell lungTherapeusisContrast research
摘要:
目的 分析研究125I粒子植入治疗晚期非小细胞肺癌(NSCLC)的疗效及不良反应。方法 对确诊的晚期NSCLC患者由放射治疗计划系统(TPS)制定方案,通过CT影像引导植入125I粒子,并行剂量学验证和定期复查。结果 89例125I植入组和25例化疗对照组总有效率分别为97%和20%,两者具有显著性差异(χ2=64.92,P<0.01)。结论 125I植入治疗晚期NSCLC具有肯定的疗效和较轻微的副作用。
Abstract:
Objective To analyze, research and process curative effect and damaging effect of terminal non small cell lung carcinoma(NSCLC). Methods Under treatment planning system and CT image guided, 125I seeds were implanted in 89 case confirmed terminal NSCLC and posologic validation and recheck termly. Results The total efficient rate of brachytherapy and chemotherapy group respectively is 97% and 20%. They have the significant difference(χ2=64.92, P<0.01). Conclusion The therapy of radioactive 125I seeds implantation is resulfful. But it unavoidably has low-grade damaging effect.

参考文献/References:

1 中华医学会.临床技术操作规范放射肿瘤分册.北京:人民军医出版社,2005.117-118.
2 陈名,蒋国梁,朱国培.放射肿瘤学临床前瞻性随机试验的设计和实施.见:蒋国梁.现代肿瘤放射治疗学.上海:上海科技出版社,2003.673.
3 Turrisi AT. A case against surgery for most Ⅲa non small cell lung cancer. Semin Oncol, 2005, 32(2 Suppl 3):S6-8.
4 朱广迎,祝淑钗,吕长兴,等.肺癌.见:朱广迎.放射肿瘤学(笫二版).北京:科学技术文献出版社,2007.325-326.
5 Gandara DR, Chansky K, Albain KS, et al. Long-term survival with concurrent chemoradlation therapy followed by consolidation docetaxel in stage ⅢB non-small-cell lung cancer:a phase Ⅱ Southwest Oncology Group Study (S9504). Clin Lung Cancer, 2006, 8(2):116-121.
6 Heelan RT, Hilaris BS, Anderson LL, et al. Lung tumors:percutaneous implantation of I-125 sources with CT treatment planning. J Radiology. 1987, 164(3):735-740.
7 Valentin J, Low-dose extrapolation of radlation-related cancer risk. Ann ICRP, 2005, 35(4):1-140.
8 Ye SJ, Brezovich IA, Shen S, et al. Dose errors due to inhomogeneities in balloon catheter brachytherapy for breast cancer. Int J Radiat Oncol Biol Phys, 2004, 60(2):672-677.
9 Siebert FA, Kohr P, Kovacs G.Comparison of CT-and radiographbased post-implant doslmetry for transperineal 125I prostate brachytherapy using single seeds and a commercial treatment-planning software. Strahlenther Onkol, 2006, 182(2):96-101.
10 Taussky D, Yeung I, Williams T, et al.Rectal-wall dose dependence on postplan timing after permanent-seed prostate brachytherapy. Int J Radiat Oncol Biol Phys, 2006, 65(2):358-363.
11 中华医学会.临床诊疗指南肿瘤分册.北京:人民卫生出版社,2005:117-118.
12 Li DF, Cui Q, Wang Q, et al. Application of I(125) brachytherapy combined artificial joint prosthesis in malignant osteo-and soft-tissue sarcoma. Cancer Biother Radiopharm. 2006. 21(2):167-172.

相似文献/References:

[1]梁雯丽,郑艳,李娜,等.Graves甲亢患者131I治疗后早期TRAb及TSAb变化的研究分析[J].国际放射医学核医学杂志,2016,40(1):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
 Liang Wenli,Zheng Yan,Li Na,et al.Analysis of the changes in early TRAb and TSAb after 131I treatment for patients with Graves hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
[2]周玉祥,蓝博文,黄春榆,等.64排螺旋CT冠状动脉血管成像诊断冠状动脉-肺动脉瘘的应用价值[J].国际放射医学核医学杂志,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
 Zhou Yuxiang,Lan Bowen,Huang Chunyu,et al.Clinical value of coronary artery-pulmonary artery fistula revealed by 64-slice spiral CT coronary angiography[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
[3]陈超坤,刘亮,傅飞先,等.囊性胸腺瘤和囊性畸胎瘤的影像学特征及鉴别诊断[J].国际放射医学核医学杂志,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
 Chen Chaokun,Liu Liang,Fu Feixian,et al.Imaging features and differential diagnosis of cystic thymoma and cystic teratoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
[4]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
 Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[5]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
 Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[6]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
 Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[7]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
 Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[8]周翠屏,廖俊杰,何国华,等.原发性肠系膜巨大淋巴结增生症的MSCT表现与病理对照分析[J].国际放射医学核医学杂志,2016,40(3):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
 Zhou Cuiping,Liao Junjie,He Guohua,et al.Primary mesenteric Castleman disease:MSCT findings with histopathologic correlation[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
[9]邓艳,张伟.125I-碘酞酸盐临床应用进展[J].国际放射医学核医学杂志,2016,40(3):225.[doi:10.3760/cma.j.issn.1673-4114.2016.03.012]
 Deng Yan,Zhang Wei.125I-iothalamate clinical applications[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):225.[doi:10.3760/cma.j.issn.1673-4114.2016.03.012]
[10]张巧娜,刘汉东.上颌窦上皮-肌上皮癌的CT表现一例[J].国际放射医学核医学杂志,2016,40(3):237.[doi:10.3760/cma.j.issn.1673-4114.2016.03.015]
[11]汤敏敏,刘建中,武志芳,等.分化型甲状腺癌患者131I治疗后体内残留放射性活度的评估[J].国际放射医学核医学杂志,2014,38(6):363.[doi:10.3760/cma.j.issn.1673-4114.2014.06.004]
 Tang Min-min,Liu Jian-zhong,Wu Zhi-fang,et al.Estimation of residual activities in patients with differentiated thyroid cancer after administration of 131I for therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):363.[doi:10.3760/cma.j.issn.1673-4114.2014.06.004]
[12]胡丽丽,李小东,张雪宁,等.影像引导下125I粒子植入治疗肺癌的疗效分析[J].国际放射医学核医学杂志,2013,37(4):203.[doi:10.3760/cma.j.issn.1673-4114.2013.04.004]
 HU Li-li,LI Xiao-dong,ZHANG Xue-ning,et al.Efficacy of CT guided radioactive 125I seed implantation in the treatment of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(6):203.[doi:10.3760/cma.j.issn.1673-4114.2013.04.004]
[13]朱晓珉,方文岩,陈军,等.CT导向下125I粒子植入治疗难治生肺癌的疗效观察[J].国际放射医学核医学杂志,2011,35(2):114.[doi:10.3760/cma.j.issn.1673-4114.2011.02.012]
 ZHU Xiao-min,FANG Wen-yan,CHEN Jun,et al.CT guided interstitial 125I seed implantation treatment of refractory lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(6):114.[doi:10.3760/cma.j.issn.1673-4114.2011.02.012]
[14]梁吉祥,柴树德,郑广钧,等.CT引导下植入125I粒子治疗非小细胞肺癌切除术后局部复发的疗效[J].国际放射医学核医学杂志,2011,35(3):181.[doi:10.3760/cma.j.issn.1673-4114.2011.03.012]
 LIANG Ji-xiang,CHAI Shu-de,ZHENG Guang-jun,et al.CT-guided percutaneous interstitial implantation of 125I for recurrent patients of postoperative non-small cell lung carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(6):181.[doi:10.3760/cma.j.issn.1673-4114.2011.03.012]
[15]孔维静,徐颖.综合干预措施下评估首次131I清甲治疗对分化型甲状腺癌患者唾液腺的慢性损伤[J].国际放射医学核医学杂志,2018,(1):30.[doi:10.3760/cma.j.issn.1673-4114.2018.01.006]
 Kong Weijing,Xu Ying.Assessment of the chronic injury of salivary glands in patients with differentiated thyroid cancer who underwent comprehensive intervention measures with first 131I clearing therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(6):30.[doi:10.3760/cma.j.issn.1673-4114.2018.01.006]
[16]南楠,朱小华.分化型甲状腺癌131I显像假阳性的原因分析[J].国际放射医学核医学杂志,2018,(1):62.[doi:10.3760/cma.j.issn.1673-4114.2018.01.012]
 Nan Nan,Zhu Xiaohua.Analysis of the false positive findings on 131I whole-body scan in differentiated thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(6):62.[doi:10.3760/cma.j.issn.1673-4114.2018.01.012]
[17]王任飞,田小丽,谭建,等.腰椎能谱CT评估Graves甲状腺功能亢进症患者131I治疗前后骨量变化的价值[J].国际放射医学核医学杂志,2018,(6):495.[doi:10.3760/cma.j.issn.1673-4114.2018.06.004]
 Wang Renfei,Tian Xiaoli,Tan Jian,et al.Changes of bone mass in patients with Graves’ hyperthyroidism before and after 131I therapy based on CT spectral imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(6):495.[doi:10.3760/cma.j.issn.1673-4114.2018.06.004]

备注/Memo

备注/Memo:
收稿日期:2007-08-01。
通讯作者:赵洪刚,E-mail:zhaohonggangzhg@sina.com
更新日期/Last Update: 1900-01-01